Lineage Cell Therapeutics In shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $41k | 37k | 1.09 |
| 2023-09-30 | $35k | 30k | 1.18 |
| 2023-06-30 | $37k | 27k | 1.41 |
| 2023-03-31 | $420k | 280k | 1.50 |
| 2022-12-31 | $17k | 14k | 1.17 |
| 2022-06-30 | $127k | 80k | 1.58 |
| 2022-03-31 | $196k | 127k | 1.54 |
| 2021-12-31 | $241k | 99k | 2.45 |
| 2021-09-30 | $248k | 97k | 2.55 |
| 2021-03-31 | $467k | 199k | 2.35 |
| 2020-06-30 | $105k | 121k | 0.87 |
| 2019-12-31 | $88k | 99k | 0.89 |
| 2019-09-30 | $44k | 45k | 0.98 |